Notice for tafasitamab (Specialised Therapeutics Alim Pty Ltd)
Active ingredients
tafasitamab
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
powder for solution for infusion
Indication
Treatment of follicular lymphoma
Therapeutic area
Haematology